Z Geburtshilfe Neonatol 2024; 228(02): 174-180
DOI: 10.1055/a-2165-8307
Original Article

Evaluation of the “Neonatal Sequential Organ Failure Assessment” to Predict Mortality in Late-Onset Sepsis in Very Preterm Infants

Elvis Kraja
1   Department of Pediatrics, Division of Neonatology, Ankara University, Faculty of Medicine, Ankara, Turkey
,
1   Department of Pediatrics, Division of Neonatology, Ankara University, Faculty of Medicine, Ankara, Turkey
,
1   Department of Pediatrics, Division of Neonatology, Ankara University, Faculty of Medicine, Ankara, Turkey
,
Nazmiye Turker
2   Department of Pediatrics, Ankara University, Faculty of Medicine, Ankara, Turkey
,
Emel Okulu
3   Division of Neonatology, Ankara University, Ankara, Turkey
,
Ömer Erdeve
1   Department of Pediatrics, Division of Neonatology, Ankara University, Faculty of Medicine, Ankara, Turkey
,
Begum Atasay
1   Department of Pediatrics, Division of Neonatology, Ankara University, Faculty of Medicine, Ankara, Turkey
,
Saadet Arsan
1   Department of Pediatrics, Division of Neonatology, Ankara University, Faculty of Medicine, Ankara, Turkey
› Author Affiliations

Abstract

Introduction We aimed to evaluate the use of “Neonatal Sequential Organ Failure Assessment” (nSOFA) scoring in predicting mortality, to compare the accuracy of nSOFA scores at different time points in very preterm infants with late-onset sepsis (LOS), and to investigate other possible parameters that would improve the prediction.

Methods This single-center, retrospective study included preterm infants born atS<32 weeks’ gestation with culture-proven LOS. The nSOFA scores of non-fatal and fatal episodes were compared at nine time points.

Results Of 120 culture-proven LOS episodes in 106 infants, 90 (75%) episodes were non-fatal and 30 (25%) episodes were fatal. The mean birth weight (BW) of the infants who died was lower than that of survivors (p=0.038). In the fatal LOS episodes, median nSOFA scores were higher at all time points measured before sepsis evaluation, at the time of evaluation, and at all time points measured after the evaluation (p<0.001). nSOFA scores before death and at 48 hours were higher in the fatal episodes (p<0.001). At the time of sepsis assessment, nSOFA score>4 was associated with a 7- to 16-fold increased risk of mortality. Adjustment for BW, lymphocyte and monocyte counts increased the risk to 9- to 18-fold.

Conclusion This study demonstrated that the use of nSOFA to predict mortality and morbidity in extremely preterm infants seems feasible. The scoring system could be improved by evaluating the other parameters.



Publication History

Received: 21 March 2023

Accepted: 02 September 2023

Article published online:
11 December 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Stoll BJ, Hansen NI, Adams-Chapman I. et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292: 2357-2365
  • 2 Stoll BJ, Hansen NI, Bell EF. et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993–2012. JAMA 2015; 314: 1039-1051
  • 3 Stoll BJ, Hansen N, Fanaroff AA. et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110: 285-291
  • 4 Greenberg RG, Kandefer S, Do BT. et al. Late-onset sepsis in extremely premature infants: 2000-2011. Pediatr Infect Dis J 2017; 36: 774-779
  • 5 Boghossian NS, Page GP, Bell EF. et al Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births. J Pediatr 2013; 162: 1120-1124 1124.e1
  • 6 Singer M, Deutschman CS, Seymour CW. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315: 801-810
  • 7 Matics TJ, Sanchez-Pinto LN. Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the sepsis-3 definitions in critically ill children. JAMA Pediatr 2017; 171: e172352
  • 8 Sanchez-Pinto LN, Parker WF, Mayampurath A. et al. Evaluation of organ dysfunction scores for allocation of scarce resources in critically ill children and adults during a healthcare crisis. Crit Care Med 2021; 49: 271-281
  • 9 Wynn JL, Polin RA. A neonatal sequential organ failure assessment score predicts mortality to late-onset sepsis in preterm very low birth weight infants. Pediatr Res 2020; 88: 85-90
  • 10 Fleiss N, Coggins SA, Lewis AN. et al. Evaluation of the neonatal sequential organ failure assessment and mortality risk in preterm infants with late-onset infection. JAMA Netw Open 2021; 4: e2036518
  • 11 Wynn JL, Mayampurath A, Carey K. et al. Multicenter validation of the neonatal sequential organ failure assessment score for prognosis in the neonatal intensive care unit. J Pediatr 2021; 236: 297-300.e1
  • 12 Kurul Ş, Simons SHP, Ramakers CRB. et al. Association of inflammatory biomarkers with subsequent clinical course in suspected late onset sepsis in preterm neonates. Crit Care 2021; 25: 12
  • 13 Brown JVE, Meader N, Wright K. et al. Assessment of C-Reactive protein diagnostic test accuracy for late-onset infection in newborn infants: a systematic review and meta-analysis. JAMA Pediatr 2020; 174: 260-268
  • 14 Benitz WE, Han MY, Madan A. et al. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998; 102: E41
  • 15 Perrone S, Lotti F, Longini M. et al. C-reactive protein in healthy term newborns during the first 48 hours of life. Arch Dis Child Fetal Neonatal Ed 2018; 103: F163-F166
  • 16 Hofer N, Zacharias E, Müller W. et al. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 2012; 102: 25-36
  • 17 Hisamuddin E, Hisam A, Wahid S. et al. Validity of C-reactive protein (CRP) for diagnosis of neonatal sepsis. Pak J Med Sci 2015; 31: 527-531
  • 18 Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000; 106: 1387-1390